Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Krystal Matthews"'
Autor:
Lindsey A. Moser, Lisbeth Ramirez-Carvajal, Vinita Puri, Steven J. Pauszek, Krystal Matthews, Kari A. Dilley, Clancy Mullan, Jennifer McGraw, Michael Khayat, Karen Beeri, Anthony Yee, Vivien Dugan, Mark T. Heise, Matthew B. Frieman, Luis L. Rodriguez, Kristen A. Bernard, David E. Wentworth, Timothy B. Stockwell, Reed S. Shabman
Publikováno v:
mSystems, Vol 1, Iss 3 (2016)
ABSTRACT Several biosafety level 3 and/or 4 (BSL-3/4) pathogens are high-consequence, single-stranded RNA viruses, and their genomes, when introduced into permissive cells, are infectious. Moreover, many of these viruses are select agents (SAs), and
Externí odkaz:
https://doaj.org/article/87969258f0004a58b311c0229c792bbc
Autor:
Matthew Frieman, Dipanwita Basu, Krystal Matthews, Justin Taylor, Grant Jones, Raymond Pickles, Ralph Baric, Daniel A Engel
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28479 (2011)
Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is
Externí odkaz:
https://doaj.org/article/1ba1d0ba5409485daa2ab893f907e543
Autor:
Chloe Keller, Lauren Baracco, Marisa McGrath, Alexander D. MacKerell, Matthew B. Frieman, Krystal Matthews, Peter B. Jahrling, James Logue, Michael R. Holbrook, Janie Liang, Lisa E. Hensley, Julie Dyall, Wenbo Yu, Stuart Weston
Publikováno v:
Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences
The SARS-CoV-2 pandemic has made it clear that we have a desperate need for antivirals. We present work that the mammalian SKI complex is a broad-spectrum, host-directed, antiviral drug target. Yeast suppressor screening was utilized to find a functi
Autor:
Susan R. Weiss, Krystal Matthews, Hanako M. Reyes, James Logue, Robert Haupt, Christopher M. Coleman, Stuart Weston, Yize Li, Matthew B. Frieman
Publikováno v:
Journal of Virology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China at the end of 2019 and has rapidly caused a pandemic, with over 20 million recorded COVID-19 cases in August 2020 (https://covid19.who.int/). There are no FDA-approved anti
Autor:
Stuart, Weston, Christopher M, Coleman, Robert, Haupt, James, Logue, Krystal, Matthews, Yize, Li, Hanako M, Reyes, Susan R, Weiss, Matthew B, Frieman
Publikováno v:
Journal of Virology
There are no FDA-approved antivirals for any coronavirus, including SARS-CoV-2. Numerous drugs are already approved for human use that may have antiviral activity and therefore could potentially be rapidly repurposed as antivirals. Here, we present d
Autor:
James Logue, Rob Haupt, Christopher M. Coleman, Stuart Weston, Krystal Matthews, Matthew B. Frieman, Jeanne M. Sisk
SARS-CoV-2 emerged in China at the end of 2019 and has rapidly become a pandemic with roughly 2.7 million recorded COVID-19 cases and greater than 189,000 recorded deaths by April 23rd, 2020 (www.WHO.org). There are no FDA approved antivirals or vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e61937e56268b62dc0889ecdb09750
Autor:
Rob Haupt, Stuart Weston, Matthew B. Frieman, Rachel Lent, Krystal Matthews, Tami J. Kingsbury, Alexandra Vlk
Publikováno v:
Journal of Virology
Viral proteins must intimately interact with the host cell machinery during virus replication. Here, we used the yeast Saccharomyces cerevisiae as a system to identify novel functional interactions between viral proteins and eukaryotic cells. Our wor
Autor:
Ka Man V. Lai, Christopher M. Coleman, Kristen E. Pascal, Alejandro O. Mujica, Christos A. Kyratsous, Robert Babb, Vishal Kamat, Matthew B. Frieman, Ashok Badithe, Krystal Matthews, Neil Stahl, Charleen Hunt, Alexander Berrebi, Tammy T. Huang, Jeanne M. Sisk, Gang Chen, Jeanette L. Fairhurst, George D. Yancopoulos, William C. Olson, John Strein
Publikováno v:
Proceedings of the National Academy of Sciences
Traditional approaches to antimicrobial drug development are poorly suited to combatting the emergence of novel pathogens. Additionally, the lack of small animal models for these infections hinders the in vivo testing of potential therapeutics. Here
Autor:
Matthew B. Frieman, Angela Franciska Haczku, Melissa D. Sánchez, Moyar Q. Ge, Krystal Matthews, Deepika Jain, Cynthia J. Koziol-White, Carolina B. López, Won-Keun Kim, Reynold A. Panettieri
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
American journal of respiratory and critical care medicine, vol 189, iss 4
American journal of respiratory and critical care medicine, vol 189, iss 4
RationaleRespiratory viral infections can result in the establishment of chronic lung diseases. Understanding the early innate immune mechanisms that participate in the development of chronic postviral lung disease may reveal new targets for therapeu
Autor:
Matthew B. Frieman, Mark T. Heise, Kristen A. Bernard, Krystal Matthews, Clancy W. Mullan, Anthony Yee, Vivien G. Dugan, Timothy B. Stockwell, Michael Khayat, Kari A. Dilley, Lisbeth Ramirez-Carvajal, Vinita Puri, Karen Beeri, Luis L. Rodriguez, David E. Wentworth, Lindsey A. Moser, Steven J. Pauszek, Reed S. Shabman, Jennifer McGraw
Publikováno v:
mSystems
mSystems, Vol 1, Iss 3, p e00039-15 (2016)
mSystems, Vol 1, Iss 3 (2016)
mSystems, Vol 1, Iss 3, p e00039-15 (2016)
mSystems, Vol 1, Iss 3 (2016)
This report establishes and validates a standard operating procedure (SOP) for select agents (SAs) and other biosafety level 3 and/or 4 (BSL-3/4) RNA viruses to rapidly generate noninfectious, barcoded cDNA amenable for next-generation sequencing (NG